These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32859628)

  • 1. Recurrent Fusion of the GRB2 Associated Binding Protein 1 (
    Panagopoulos I; Gorunova L; Andersen K; Tafjord S; Lund-Iversen M; Lobmaier I; Micci F; Heim S
    Cancer Genomics Proteomics; 2020; 17(5):499-508. PubMed ID: 32859628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GAB1::ABL1 fusions define a distinctive soft tissue neoplasm, with variable perineurial differentiation, and a predilection for children and young adults.
    Agaimy A; Perret R; Demicco EG; Gross J; Liu YJ; Azmani R; Engelmann C; Schubart C; Seppet J; Stoehr R; Le Loarer F; Dickson BC
    Genes Chromosomes Cancer; 2023 Aug; 62(8):449-459. PubMed ID: 36744864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GAB1-ABL1 fusions in tumors that have histologic overlap with NTRK-rearranged spindle cell tumors.
    Choo F; Rakheja D; Davis LE; Davare M; Park JY; Timmons CF; Neff T; Beadling C; Corless CL; Davis JL
    Genes Chromosomes Cancer; 2021 Sep; 60(9):623-630. PubMed ID: 34036664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABL1 gene involvement within a complex three-way translocation (2;9;4) in perineurioma characterized by molecular cytogenetic methods.
    Duff DJ; Guzman MA; Batanian JR
    Cancer Genet; 2014 Jun; 207(6):263-7. PubMed ID: 25074247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).
    De Keersmaecker K; Graux C; Odero MD; Mentens N; Somers R; Maertens J; Wlodarska I; Vandenberghe P; Hagemeijer A; Marynen P; Cools J
    Blood; 2005 Jun; 105(12):4849-52. PubMed ID: 15713800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia.
    Ernst T; Score J; Deininger M; Hidalgo-Curtis C; Lackie P; Ershler WB; Goldman JM; Cross NC; Grand F
    Br J Haematol; 2011 Apr; 153(1):43-6. PubMed ID: 21391972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.
    Sindt A; Deau B; Brahim W; Staal A; Visanica S; Villarese P; Rault JP; Macintyre E; Delabesse E
    Genes Chromosomes Cancer; 2006 Jun; 45(6):575-82. PubMed ID: 16518848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias.
    Duhoux FP; Auger N; De Wilde S; Wittnebel S; Ameye G; Bahloula K; Van den Berg C; Libouton JM; Saussoy P; Grand FH; Demoulin JB; Poirel HA
    Leuk Res; 2011 Jul; 35(7):e114-7. PubMed ID: 21388681
    [No Abstract]   [Full Text] [Related]  

  • 9. ABL1 rearrangements in T-cell acute lymphoblastic leukemia.
    Hagemeijer A; Graux C
    Genes Chromosomes Cancer; 2010 Apr; 49(4):299-308. PubMed ID: 20073070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias.
    Biloglav A; Olsson-Arvidsson L; Theander J; Behrendtz M; Castor A; Johansson B
    Genes Chromosomes Cancer; 2020 Sep; 59(9):540-543. PubMed ID: 32306475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
    Chiaretti S; Tavolaro S; Ghia EM; Ariola C; Matteucci C; Elia L; Maggio R; Messina M; Ricciardi MR; Vitale A; Ritz J; Mecucci C; Guarini A; Foà R
    Haematologica; 2007 May; 92(5):619-26. PubMed ID: 17488685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.
    La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C
    Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript.
    Masuzawa A; Kiyotani C; Osumi T; Shioda Y; Iijima K; Tomita O; Nakabayashi K; Oboki K; Yasuda K; Sakamoto H; Ichikawa H; Hata K; Yoshida T; Matsumoto K; Kiyokawa N; Mori T
    Eur J Haematol; 2014 Mar; 92(3):263-7. PubMed ID: 24215620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a cryptic
    Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Koon SJ; Webley MR; McGrath M; Bayerl MG; Baughn LB; Rowsey RA; Ketterling RP; Greipp PT; Hoppman NL
    Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft tissue angiofibroma: Clinicopathologic, immunohistochemical and molecular analysis of 14 cases.
    Bekers EM; Groenen PJTA; Verdijk MAJ; Raaijmakers-van Geloof WL; Roepman P; Vink R; Gilhuijs NDB; van Gorp JM; Bovée JVMG; Creytens DH; Flanagan AM; Suurmeijer AJH; Mentzel T; Arbajian E; Flucke U
    Genes Chromosomes Cancer; 2017 Oct; 56(10):750-757. PubMed ID: 28639284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of the SEPT9-ABL1 chimeric fusion gene derived from T-prolymphocytic leukemia.
    Kawai H; Matsushita H; Suzuki R; Sheng Y; Lu J; Matsuzawa H; Yahata T; Tsuma-Kaneko M; Tsukamoto H; Kawada H; Ogawa Y; Ando K
    Leuk Res; 2014 Dec; 38(12):1451-9. PubMed ID: 25217890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
    Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y
    Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations.
    Inokuchi K; Wakita S; Hirakawa T; Tamai H; Yokose N; Yamaguchi H; Dan K
    Int J Hematol; 2011 Sep; 94(3):255-260. PubMed ID: 21863287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD).
    Duan MH; Li H; Cai H
    Leuk Res; 2017 Aug; 59():8-11. PubMed ID: 28527402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases, by Tamborini E., et al.
    O'Sullivan MJ; Pfeifer JD; Dehner LP
    Lab Invest; 2003 Mar; 83(3):301-2; author reply 302-3. PubMed ID: 12649331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.